Astek Diagnostics Analysis: $2M Raised
What is Astek Diagnostics?
Astek Diagnostics develops the JIDDU system for rapid urinary tract infection detection and antibiotic sensitivity indication, enhancing patient care and reducing healthcare costs.
Employees
5
Founded
2020
Revenue
$1-5M
Product Features & Capabilities
- 1-hour UTI detection, antibiotic sensitivity indication, rapid confirmation of urinary tract infections, actionable results, universal diagnostic system for multiple sample types (urine, CSF, effluent, blood).
How much Astek Diagnostics raised
1 - $2 million
Not specifiedLead Investor: Not specified
Investors
- TEDCO
- She's Independent
- Y Combinator
- AYANA Capital
- Wexford SciTech Venture Fund
- Harvard Management Seed Capital
- National Science Foundation
- MedTech Innovator
Business Model
Revenue from diagnostic tests and potential partnerships with healthcare providers and institutions.
Competitors Overview
Astek Diagnostics operates in the clinical diagnostics market, focusing on rapid testing for urinary tract infections (UTIs) and antibiotic sensitivity. Its main competitors include:
- Bainbridge Health: While specific details about their offerings were not found, they are noted as a competito
Market Focus
Astek Diagnostics primarily focuses on the clinical diagnostics market, specifically in developing rapid diagnostic solutions for urinary tract infections (UTIs) and antibiotic sensitivity testing.
See something that needs updating? Suggest edits to this profile.